Lv1
30 积分 2025-08-13 加入
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1年前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1年前
已完结
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
1年前
已完结
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
1年前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
1年前
已完结
Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials
1年前
已完结
SOHO State of the Art Updates and Next Questions | CD7 CAR-T Therapy for Treating CD7-Positive Hematological Malignancies: Clinical Advances and Future Directions
1年前
已完结